SEC Comment Letter for CYTRX CORP (LADX) (CIK 0000799698) (LADX) — Aug 10, 2021
CYTRX CORP (LADX) (CIK 0000799698)
Date: Aug. 10, 2021 · CIK: 0000799698 · Accession: 0000000000-21-009777
AI Filing Summary & Sentiment
File numbers found in text: 333-258453
Letter
United States securities and exchange commission logo August 10, 2021 Steven Kriegsman Chairman and Chief Executive Officer CytRx Corporation 11726 San Vicente Boulevard, Suite 650 Los Angeles, CA 90049 Re:CytRx Corporation Registration Statement on Form S-1 Filed August 4, 2021 File No. 333-258453 Dear Mr. Kriegsman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jayun Koo
Show Raw Text
United States securities and exchange commission logo
August 10, 2021
Steven Kriegsman
Chairman and Chief Executive Officer
CytRx Corporation
11726 San Vicente Boulevard, Suite 650
Los Angeles, CA 90049
Re:CytRx Corporation
Registration Statement on Form S-1
Filed August 4, 2021
File No. 333-258453
Dear Mr. Kriegsman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jayun Koo